BB Biotech AG | Cash Flow

Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
Other Funds
132,776.00
-
-
-
-
Funds from Operations
117,072.00
121,651.00
52,396.00
114,316.00
262,926.00
Net Operating Cash Flow
117,072.00
121,651.00
52,396.00
114,316.00
262,926.00
Cash Dividends Paid - Total
51,019.00
79,429.00
130,079.00
160,489.00
152,066.00
Issuance/Reduction of Debt, Net
45,000.00
60,000.00
130,000.00
45,000.00
110,000.00
Net Financing Cash Flow
92,581.00
157,288.00
38,971.00
125,724.00
262,431.00
Net Change in Cash
24,842.00
34,731.00
12,091.00
10,830.00
501.00
Free Cash Flow
117,072.00
121,651.00
52,396.00
114,316.00
262,926.00
Change in Capital Stock
129,338.00
17,859.00
38,892.00
10,235.00
365.00
Exchange Rate Effect
351.00
906.00
1,334.00
578.00
6.00

About BB Biotech

View Profile
Address
Schwertstrasse 6
Schaffhausen Zurich 8200
Switzerland
Employees -
Website http://www.bbbiotech.com
Updated 09/14/2018
BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.